PTTG Expression as a Marker for Tumor Recurrence in Head and Neck Cancer
Author Information
Author(s): Christine Solbach, Marc Roller, Frank Eckerdt, Silke Peters, Rainald Knecht
Primary Institution: Johann Wolfgang Goethe University School of Medicine
Hypothesis
Can PTTG mRNA expression serve as a prognostic marker for tumor recurrence in squamous cell carcinoma of the head and neck?
Conclusion
Elevated PTTG transcript levels might be used as a prognostic biomarker for future clinical outcome in primary squamous cell carcinomas of the head and neck.
Supporting Evidence
- PTTG was overexpressed in almost all tumor samples compared to unaffected tissue.
- Higher PTTG expression was significantly associated with tumor recurrence.
- The median PTTG expression in recurrent tumors was significantly higher than in non-recurrent tumors.
Takeaway
This study found that a gene called PTTG is often found in higher amounts in tumors that come back after treatment, which might help doctors predict if a cancer will return.
Methodology
Tumor samples from 89 patients were analyzed for PTTG mRNA expression and compared to unaffected tissue, with correlations made to clinical outcomes over a five-year period.
Limitations
The study focused only on PTTG expression and did not correlate it with other standard prognostic factors or patient survival.
Participant Demographics
89 patients (78 male, 11 female) with a median age of 54 years, all were smokers and regular alcohol consumers.
Statistical Information
P-Value
0.009
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website